Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
07/28/1999 | CN1044324C Process for preparing ecological preparation of Bacillus licheniformis |
07/28/1999 | CN1044323C Process for preparing donkey-hide gelatin effervescent infusion |
07/28/1999 | CN1044322C Active oral China medicinal stone solution and preparing method |
07/27/1999 | US5929222 Expression of a foamy virus envelope protein |
07/27/1999 | US5929113 Compositions comprising EMU oil or active fractions thereof and methods of using these compositions as insect repellents |
07/27/1999 | US5929109 Enhancing and stabilizing agent of the activity of Bifidus factor |
07/27/1999 | US5928892 Mutant factor b with one or more amino acids in short consensus repeat domain or von willebrand factor domain replaced by corresponding region of second protein; altered activity; treatment of autoimmune disease; imunosuppressants |
07/27/1999 | US5928639 Immunotherapy of cancer with allogeneic lymphocytes |
07/27/1999 | US5928469 Process for storage of materials |
07/27/1999 | US5928214 System for concentrating blood cells |
07/27/1999 | CA2049056C Cell capsule extrusion systems |
07/26/1999 | CA2259878A1 System and methods for handling fluids |
07/23/1999 | CA2227827A1 In vitro artificial cornea and sclera |
07/22/1999 | WO1999036562A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
07/22/1999 | WO1999036557A1 Novel promoter elements for persistent gene expression |
07/22/1999 | WO1999036545A2 Adenoviral vectors with modified capsid proteins |
07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
07/22/1999 | WO1999036111A1 System and method for separation of particles |
07/22/1999 | WO1999036079A1 A noncleavable fas ligand |
07/22/1999 | WO1999036078A1 Analgesic from snake venom |
07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
07/22/1999 | WO1999036052A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
07/22/1999 | WO1999025814B1 Genetically-modified myogenic progenitors and their use in cell and gene therapy |
07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
07/22/1999 | CA2318279A1 Analgesic from snake venom |
07/22/1999 | CA2317956A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
07/22/1999 | CA2317941A1 Adenoviral vectors with modified capsid proteins |
07/22/1999 | CA2317934A1 Novel promoter elements for persistent gene expression |
07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
07/21/1999 | EP0930009A1 Quiescent cell population for nuclear transfer |
07/21/1999 | EP0929671A1 Method for treating amyotrophic lateral sclerosis |
07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
07/21/1999 | EP0929328A1 Method for removing tumor cells from tumor cell-contaminated stem cell products |
07/21/1999 | EP0929322A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
07/21/1999 | EP0929318A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
07/21/1999 | EP0929308A1 Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process |
07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
07/21/1999 | EP0929271A1 Prosthetic kidney and its use for treating kidney disease |
07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
07/21/1999 | CN1223689A Brain glycogen phosphorylase cancer antigen |
07/21/1999 | CN1223586A Recombinant vaccine for diseases caused by encapsulated organisms |
07/21/1999 | CN1223573A Enteric coating, comprising alginic acid, for an oral preparation |
07/21/1999 | CN1223144A Weikang traditional Chinese medicine capsule |
07/21/1999 | CN1223141A Liquor for treating rheumatism and arthritis |
07/21/1999 | CN1223140A Health care food and production method thereof |
07/21/1999 | CN1223139A Yanminling nose-spraying agent and preparation process |
07/21/1999 | CN1223136A Quick-acting preparation for litholysis |
07/21/1999 | CN1223134A Ointment for eliminating pain of spur and preparation process thereof |
07/21/1999 | CN1223133A Medicine for curing hepatitis B |
07/21/1999 | CN1223132A Medicine for curing dermatosis |
07/21/1999 | CN1223131A Medicine for curing waist sprain and contusion |
07/21/1999 | CN1223127A Tongguanshugan ointment and preparation process thereof |
07/21/1999 | CN1223119A Traditional Chinese medicinal preparation for curing gynecopathy |
07/21/1999 | CN1223118A Process for producing biological active calcium |
07/21/1999 | CN1223117A Embryo like health-care preparation and preparation process thereof |
07/20/1999 | US5925751 Human cytomegalovirus DNA sequences |
07/20/1999 | US5925738 Stable aqueous liquid of plasma protein, buffer, calcium ions, and osmotic modulating agent; for treatment of blood disorders by administration of blood coagulation factors |
07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
07/20/1999 | US5925565 Internal ribosome entry site, vector containing it and therapeutic use |
07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
07/20/1999 | US5925550 Method for selectively increasing the ratio of single major components of antibiotic A/16686 complex |
07/20/1999 | US5925382 Antioxidant composition and method for production thereof |
07/20/1999 | US5925333 Screening for compounds that alter the binding by scavengers |
07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
07/16/1999 | CA2258948A1 Chimeric poxvirus comprising sequences of a vector component |
07/15/1999 | WO1999035495A2 Identification of substances that modify cellular secretory function |
07/15/1999 | WO1999035277A2 Recombinant, active caspases and uses thereof |
07/15/1999 | WO1999035255A2 Compositions and methods for regulated secretion from neuroendocrine cell lines |
07/15/1999 | WO1999035245A2 Methods for preparing and using immortalized human neuroendocrine cells |
07/15/1999 | WO1999035242A1 Media for neuroendocrine cells |
07/15/1999 | WO1999034839A1 Methods for quenching pathogen inactivators in biological materials |
07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
07/15/1999 | WO1999034804A1 A2a adenosine receptor agonists |
07/15/1999 | WO1999034791A1 Methods and compositions for inactivating viruses |
07/15/1999 | WO1999034771A1 Composition to stop hairloss |
07/15/1999 | WO1999034680A1 Decorated red blood cells |
07/15/1999 | WO1999034669A1 Cloning using donor nuclei from differentiated fetal and adult cells |
07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
07/15/1999 | DE19813759C1 Inducing a natural killer cell immune response ex vivo |
07/15/1999 | CA2318379A1 Identification of substances that modify cellular secretory function |
07/15/1999 | CA2318376A1 Compositions and methods for regulated secretion from neuroendocrine cell lines |
07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
07/15/1999 | CA2317640A1 Decorated red blood cells |
07/15/1999 | CA2317603A1 Methods for quenching pathogen inactivators in biological materials |
07/15/1999 | CA2317494A1 Cloning using donor nuclei from differentiated fetal and adult cells |
07/15/1999 | CA2317458A1 Methods and compositions for inactivating viruses |
07/15/1999 | CA2317093A1 A2a adenosine receptor agonists |
07/14/1999 | EP0928615A1 Method for recovering and regenerating peritoneal dialyzate, apparatus therefor, and attachments thereof |
07/14/1999 | EP0928340A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
07/14/1999 | EP0928328A1 Methods for culturing cells |
07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
07/14/1999 | CN1222390A Convalescence tablet for giving up drugging and preventing and curing tumor and AIDS |
07/14/1999 | CN1222384A Anticarcinogen for liver cancer |
07/14/1999 | CN1222383A Chinese medicine for curing female endocrinopathy and its preparation |
07/14/1999 | CN1222382A Medicine bolus for hepatitis B and its preparation |
07/14/1999 | CN1222381A Medicine liquid for discharge of stone |
07/14/1999 | CN1222379A Chinese medicine pellet 'Qufengdan' for rheumatoid disease and its preparation |
07/14/1999 | CN1222378A Chinese medicine for acute and chronic diarrhea, dysentery with purulent and bloody stools, as well as acute and chronic colitis |